Tuesday, June 16, 2015

RECIST for Response (Clinical and Imaging) in Neoadjuvant Clinical Trials in Operable Breast Cancer

… document. Although approximately 70% of breast cancer patients demonstrate a clinical response …
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)